Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 75 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
741 14.1 months Bladder Cancer 5 Biologic therapy
Chemotherapy
Georges Pompidou Hospital, University Paris Descartes France 11/2014
Treatment Details: Patients: This phase 2 study involved patients with advanced or metastatic, HER2-overexpressing urothelial carcinoma who were separated into two treatment groups. Group A consisted of 29 pa
 
742 14.1 months Advanced urothelial cancer 4 Seoul National University College of Medicine Korea 11/2014
Treatment Details: Patients: This phase 2 study involved 42 advanced urothelial cancer patients. The median patient age was 66 years and 66.7% were male. Treatment: Patients received chemotherapy with pe
 
743 14.1 months Castration-resistant prostate cancer 4 Chemotherapy
San Camillo and Forlanini Hospitals Italy 10/2009
Treatment Details: Patients: This phase 3 study involved 950 men with castrate-refractory prostate cancer. They had previously been treated with chemotherapy, but their cancer had progressed. These men rang
 
744 14.0 months Platinum refractory or resistant epithelial ovarian cancer 4 Chemotherapy
MD Anderson Cancer Center, University of Texas United States 11/2010
Treatment Details: Patients: This study involved 30 women with epithelial ovarian cancer whose cancer had progressed following prior platinum-based chemotherapy. The median patient age was 63 years. Treat
 
745 14.0 months Metastatic melanoma 4 Biologic therapy
Peking University Cancer Hospital China 6/2011
Treatment Details: Patients: This study involved 43 patients with metastatic melanoma. Patients had a median age of 57 years and 46.5% were male. Treatment: Patients were treated with the biologic therap
 
746 14.0 months Malignant Pleural Mesothelioma 4 Chemotherapy
Ospedale 'Villa Scassi' Italy 12/2007
Treatment Details: Patients: This phase II study involved seventy-six patients with malignant pleural mesothelioma. The median age was 65, ranging from 40 to 75 years. The majority, 71%, were men. Trea
 
747 14.0 months metastatic breast cancer 3 Chemotherapy
Regina Elena National Cancer Institute Italy 3/2006
Treatment Details: Patients: This phase II study included 51 patients with metastatic breast cancer. Treatments: Treatment consisted of chemotherapy (paclitaxel and 5-fluorouracil) and folinic acid and
 
748 14.0 months Malignant pleural mesothelioma 5 Surgery
Memorial Sloan-Kettering Cancer Center United States 3/2008
Treatment Details: Patients: This study involved 663 patients with malignant pleural mesothelioma. There were 538 men and 125 women. The majority of patients reported that they had been exposed to asbestos.
 
749 14.0 months Metastatic renal cell carcinoma 4 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 6/2008
Treatment Details: Patients: This study involved 14 patients with metastatic renal cell carcinoma (kidney cancer). The median age was 70, ranging from 43 to 78 years. Most (86%) had previously been treated
 
750 14.0 months Metastatic colorectal cancer 4 Chemotherapy
Infermi Hospital Italy 5/2002
Treatment Details: Patients: This Phase II trial, involved 45 patients with metastatic colorectal cancer. Most patients (62%) had only one metastatic site. Treatment: Treatment consisted of the bolus admin
 
Page 75 of 187  | Previous Page  | Next Page